Physician

Gertrud Caroline Malmberg, M.D.

According to 2025 Medicare claims, Gertrud Malmberg, M.D. (NPI: 1902020373) practices general practice in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is CLIFFSIDE MEDICAL LLC (NPI: 1104908813; TIN: 22-3371929) and primary practice location at 07010-3012. Malmberg is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Malmberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 487 traditional Medicare patients, billed 2,338 HCPCS/CPT codes, and received $152,533 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,225 prescription claims across 630 beneficiaries totaling $387,991 in drug costs, led by Januvia (Sitagliptin Phosphate). DME data shows 12 claims. Open Payments data shows 5 records totaling $106. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $109,998 to $152,533. Similarly, Part D prescription costs have moved sharply higher in recent years, from $81,889 to $387,991. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $551 and ending at $494.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	610	1,708	$109,998
2016	517	1,646	$97,494
2017	692	2,266	$133,619
2018	703	2,221	$122,209
2019	570	1,975	$126,507
2020	682	2,512	$169,443
2021	627	2,332	$188,550
2022	489	1,992	$171,967
2023	558	2,551	$183,613
2024	487	2,338	$152,533

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	414	1,733	$81,889
2016	497	2,417	$120,949
2017	569	2,684	$128,140
2018	504	2,625	$150,775
2019	479	2,469	$128,598
2020	514	2,888	$213,771
2021	531	3,453	$269,718
2022	520	3,448	$296,508
2023	588	3,690	$324,376
2024	630	4,225	$387,991

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	65	$689
2016	28	68	$647
2017	31	59	$403
2018	32	76	$566
2019	14	47	$383
2020	N/R	22	$246
2021	11	56	$2,534
2022	N/R	35	$326
2023	N/R	N/R	N/R
2024	N/R	12	$143

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	278	559	$106
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	304	568	$72
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	162	225	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	145	219	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	118	128	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Januvia	Sitagliptin Phosphate	36	2,880	$50,417
Ozempic	Semaglutide	25	1,624	$49,676
Mounjaro	Tirzepatide	21	1,044	$36,745
Jardiance	Empagliflozin	26	1,800	$29,273
Xarelto	Rivaroxaban	27	1,390	$25,878

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	12	$143

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$106	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gertrud Caroline Malmberg, M.D.?

Tedicare shows public-source Medicare data for Gertrud Caroline Malmberg, M.D. (NPI 1902020373), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gertrud Caroline Malmberg, M.D. have ACO affiliation data?

Gertrud Caroline Malmberg, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Gertrud Caroline Malmberg, M.D.?

Gertrud Caroline Malmberg, M.D. is linked to CLIFFSIDE MEDICAL LLC (billing NPI 1104908813) in the available physician profile data.

Does Gertrud Caroline Malmberg, M.D. have Open Payments data?

Gertrud Caroline Malmberg, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.